Ribotyping of Erwinia chrysanthemi Strains in Relation to Their Pathogenic and Geographic Distribution.

Appl Environ Microbiol

Station de Pathologie Végétale, Institut National de la Recherche Agronomique, 78026 Versailles Cedex, France.

Published: October 1994

16S and 23S rRNAs from Escherichia coli were used to study the relationship among a representative collection of strains of Erwinia chrysanthemi differing in their original host and geographical origin. Phenetic analysis of restriction fragment length polymorphisms allowed the distribution of the studied strains into seven clusters. These clusters were similar to those obtained by cladistic methods and appeared to correlate well with the established pathovars and biovars but to a lesser extent with geographical distribution. Except for two groups of strains defined as tropical and temperate isolates (clusters 3 and 4, respectively), our clustering correlated well with botanical classifications of host plants. However, the rRNA groupings were shown to be more discriminative than biovar analysis. To assess the relationship between rRNA clusters and pathogenicity, 12 representative strains from different clusters were tested for pathogenicity on different plants. The two typical symptoms, maceration and wilting, were observed for these strains. The occurrence of the tobacco hypersensitivity reaction for a subset of these strains is discussed in light of recent results concerning the presence of an hrp gene. Considering symptom expression only, rather than the capacity for plant infection, strains from the same cluster were shown to induce similar symptoms in test plants. Thus, since host specificity is still quite controversial, rRNA patterns may constitute a useful tool in taxonomic and epidemiological studies of Erwinia chrysanthemi species.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC201887PMC
http://dx.doi.org/10.1128/aem.60.10.3781-3789.1994DOI Listing

Publication Analysis

Top Keywords

erwinia chrysanthemi
12
strains
8
strains clusters
8
clusters
5
ribotyping erwinia
4
chrysanthemi strains
4
strains relation
4
relation pathogenic
4
pathogenic geographic
4
geographic distribution
4

Similar Publications

Article Synopsis
  • L-asparaginases are enzymes that convert L-asparagine into L-aspartic acid and ammonia, and they are important in the pharmaceutical industry, particularly for cancer treatments.
  • Scientists are exploring yeast-derived L-asparaginases as an alternative to bacterial ones, which can cause adverse immune responses.
  • The study focuses on a specific yeast enzyme, Lachancea thermotolerans, demonstrating that a mutant form of this enzyme shows increased activity and significant antileukemic potential compared to commercial bacterial versions.
View Article and Find Full Text PDF

Polyethylene-glycolated -derived l-asparaginase (pegaspargase, pASP) is an essential component of paediatric-inspired regimens for the treatment of acute lymphoblastic leukaemia/lymphoma; nonetheless, is characterised by severe and potentially life-threatening toxicities, such as hypertriglyceridemia. Grades 3-4 events have been reported in ~1%-18% of paediatric patients and in sparse reports in adults. There is limited evidence on the safety of asparaginase rechallenge in patients experiencing severe pASP-related hypertriglyceridemia.

View Article and Find Full Text PDF

Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease without meaningful therapeutic options beyond the first salvage therapy. Targeting PDAC metabolism through amino acid restriction has emerged as a promising new strategy, with asparaginases, enzymes that deplete plasma glutamine and asparagine, reaching clinical trials. In this study, we investigated the anti-PDAC activity of the asparaginase formulation Pegcrisantaspase (PegC) alone and in combination with standard-of-care chemotherapeutics.

View Article and Find Full Text PDF

L-asparaginase is an essential drug used to treat acute lymphoid leukemia (ALL), a cancer of high prevalence in children. Several adverse reactions associated with L-asparaginase have been observed, mainly caused by immunogenicity and allergenicity. Some strategies have been adopted, such as searching for new microorganisms that produce the enzyme and applying protein engineering.

View Article and Find Full Text PDF

Desirable L-asparaginases for treating cancer and current research trends.

Front Microbiol

March 2024

Department of Industrial Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.

Amino acid depletion therapy is a promising approach for cancer treatment. It exploits the differences in the metabolic processes between healthy and cancerous cells. Certain microbial enzymes induce cancer cell apoptosis by removing essential amino acids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!